IPO Timeline
Broker Results (T-2)
2021-09-27
Some brokers release in afternoon
Grey Market (T-1)
2021-09-28
Afternoon
HKEX Allotment (T-1)
2021-09-28
Evening
Registrar Allotment (T-1)
2021-09-28
Evening
Listing Day (T)
2021-09-29
First day of trading
Company Overview
| Stock Name | 創勝集團醫藥有限公司 - B |
|---|---|
| Stock Code | 06628 |
| Company Full Name | 創勝集團醫藥有限公司 - B |
| Industry | 醫療保健 |
| Principal Activities | 主要從事研發、制造及商業化生物制藥。 |
| Listing Date | 2021-09-29 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國江蘇省蘇州市星湖街218號生物納米園B6-501室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.transcenta.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 16.00 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 69.6% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 258,112,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 13.24 |
|---|---|
| First Day Open | HK$ 13.0 |
| First Day Change | -17.25% |
| First Day Volume | 11079000.0 |
| First Day Turnover | 143255000.0 |
Use of Proceeds
| Use of Proceeds | 1、82%或約471.0百萬港元用于我們管線候選產品的研發、為進行中及計劃中的臨床及臨床前試驗、籌備注冊備案以及其他與商業化我們四款主打產品有關的步驟或活動撥資； 2、8%或約46.0百萬港元用于為擴充管線及開發技術的業務發展撥資； 3、10%或約57.4百萬港元用作一般營運資金及一般營運費用。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (4)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
中银国际亚洲有限公司 CE AET863
华兴证券（香港）有限公司 CE AZX839
Joint Bookrunners (4)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
中银国际亚洲有限公司 CE AET863
华兴证券（香港）有限公司 CE AZX839
Joint Lead Managers (4)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
中银国际亚洲有限公司 CE AET863
华兴证券（香港）有限公司 CE AZX839
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Aranda Investments Pte. Ltd. | 33,032,000 HKD | — | 5.12% | — | 6 months | 2022-03-29 |
| 2 | LAV Amber Limited | 52,856,000 HKD | — | 8.19% | — | 6 months | 2022-03-29 |
| 3 | QH Oil Investments LLC | 165,200,000 HKD | — | 25.60% | — | 6 months | 2022-03-29 |
| 4 | 中国国有企业结构调整基金股份有限公司 | 198,240,000 HKD | — | 30.72% | — | 6 months | 2022-03-29 |
Directors & Management
| Chairman | 錢雪明 |
|---|---|
| Company Secretary | 梁君慧 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Yi Shi(15.84%);錢雪明及家族成員(13.09%);中國國有企業結構調整基金股份有限公司(8.85%);Success Link International L.P.(8.38%);淡馬錫控股(私人)有限公司(6.31%) |
|---|
IPO Timeline
